Ex-Pharma Exec Charged With $38M Insider Trading Scheme
A former chief聽science officer聽of pharmaceutical company Humanigen faces charges in New Jersey federal court that he dumped聽shares of the company before it聽publicly announced its potential COVID-19 drug did not receive federal...To view the full article, register now.
Already a subscriber? Click here to view full article